PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19053864-6	2008	In the evaluation of effects on hepatic glucose metabolism, the ratios of glucokinase/glucose-6-phosphatase activities in the high-dose GPE- and rosiglitazone-supplemented groups were prominently higher than that of the control group.	Rosiglitazone	145-158	glucose-6-phosphatase, catalytic	Mus musculus	86-107	
18598161-5	2008	The supplementation of chungkukjang and rosiglitazone significantly elevated hepatic glucokinase activity with a simultaneous reduction of glucose-6-phosphatase and phosphoenolpyruvate carboxykinase activity in the db/db mice compared to the diabetic control mice.	Rosiglitazone	40-53	glucose-6-phosphatase, catalytic	Mus musculus	139-160	
24200792-3	2013	In liver tissue, CHS/RSG significantly normalized the activities of hexokinase, pyruvate kinase, and glucose-6-phosphatase.	Rosiglitazone	21-24	glucose-6-phosphatase, catalytic	Mus musculus	101-122